Francesco Blasi

Q: What Schools Are Affiliated With Francesco Blasi

Francesco Blasi is affiliated with the following schools: University of Cambridge, University of Insubria, McGill University, University of Milan, Vrije Universiteit Amsterdam, Icahn School of Medicine at Mount Sinai, Vita-Salute San Raffaele University, University of Copenhagen, University of Florence

Francesco Blasi's AcademicInfluence.com Rankings

Francesco Blasi

Philosophy

#2727

World Rank

#4571

Historical Rank

Logic

#748

World Rank

#1273

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Francesco Blasi's Degrees

Doctorate Medicine University of Milan
PhD Respiratory Medicine University of Milan

Why Is Francesco Blasi Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Francesco Blasi is an Italian Medical scientist and professor. His domain of research is respiratory medicine. He has been the president of European Respiratory Society during 2012–13. He has served as the president of Italian Respiratory Society during 2015–17. He is presently serving as one of the board of directors of University of Milan and is the professor of respiratory medicine in department pathophysiology and transplantation in University of Milan.

(See a Problem?)

Francesco Blasi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genomewide Association Study of Severe Covid-19 with Respiratory Failure (2020) (1425)
uPAR: a versatile signalling orchestrator (2002) (1234)
Guidelines for the management of adult lower respiratory tract infections (2005) (945)
Guidelines for the management of adult lower respiratory tract infections ‐ Full version (2011) (793)
European Respiratory Society guidelines for the management of adult bronchiectasis (2017) (684)
Towards tuberculosis elimination: an action framework for low-incidence countries (2015) (656)
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. (2005) (636)
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors (1987) (608)
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. (1990) (604)
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. (1992) (587)
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. (1991) (552)
Risk factors for community-acquired pneumonia in adults in Europe: a literature review (2013) (493)
Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. (1991) (467)
Anxiety and depression in COPD patients: The roles of gender and disease severity. (2006) (466)
Mapping the human genetic architecture of COVID-19 (2021) (455)
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. (1985) (407)
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. (1987) (399)
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy (2003) (378)
Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1. (1990) (377)
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R (2002) (364)
Guidelines for the management of adult lower respiratory tract infections--summary. (2011) (351)
Autocrine saturation of pro-urokinase receptors on human A431 cells (1986) (347)
Proteolytic cleavage of the urokinase receptor substitutes for the agonist‐induced chemotactic effect. (1996) (332)
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes (1997) (320)
Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. (2015) (307)
Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. (1995) (307)
The effect of telithromycin in acute exacerbations of asthma. (2006) (305)
uPA and uPAR in fibrinolysis, immunity and pathology. (2004) (302)
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. (1993) (284)
Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms (1996) (282)
Structure and function of epidermal growth factor‐like regions in proteins (1988) (275)
uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? (1997) (273)
Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. (2001) (266)
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. (1990) (265)
Characterization of Myocardial Injury in Patients With COVID-19 (2020) (260)
A urokinase‐sensitive region of the human urokinase receptor is responsible for its chemotactic activity (1997) (252)
A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. (1988) (247)
Segmental expression of Hoxb2 in r4 requires two separate sites that integrate cooperative interactions between Prep1, Pbx and Hox proteins. (2000) (245)
Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness (1993) (244)
The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. (1991) (243)
The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. (1999) (242)
The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling (2010) (242)
Future trends in cystic fibrosis demography in 34 European countries (2015) (233)
The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids (2005) (233)
A worldwide perspective of atypical pathogens in community-acquired pneumonia. (2007) (229)
Management of bronchiectasis in adults (2015) (227)
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease (2015) (226)
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research (2017) (221)
European Union Standards for Tuberculosis Care (2012) (219)
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. (2000) (218)
Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. (1988) (214)
Transforming growth factor‐beta is a strong and fast acting positive regulator of the level of type‐1 plasminogen activator inhibitor mRNA in WI‐38 human lung fibroblasts. (1987) (211)
Chlamydia pneumoniae infection in acute exacerbations of COPD. (1993) (210)
Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. (1984) (209)
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion (1991) (208)
alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor (1995) (205)
Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencing (1986) (201)
Complement activation in patients with COVID-19: A novel therapeutic target (2020) (201)
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic? (2007) (200)
The human urokinase-plasminogen activator gene and its promoter. (1985) (196)
Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. (2000) (195)
Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System (1999) (186)
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. (1998) (185)
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. (2012) (184)
Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. (1986) (181)
Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. (2001) (179)
Requirement for receptor‐bound urokinase in plasmin‐dependent cellular conversion of latent TGF‐β to TGF‐β (1994) (178)
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. (2013) (177)
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. (1989) (177)
Electronic cigarettes. A position statement of the forum of international respiratory societies. (2014) (176)
Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. (1991) (175)
A novel complex between the p65 subunit of NF‐kappa B and c‐Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. (1992) (174)
Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. (1992) (174)
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. (2008) (174)
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review (2014) (169)
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. (2013) (167)
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial (2021) (167)
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination (2013) (166)
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. (2013) (161)
Understanding the burden of pneumococcal disease in adults. (2012) (157)
Integrated care pathways for airway diseases (AIRWAYS-ICPs) (2014) (155)
Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. (2000) (155)
A review of national guidelines for management of COPD in Europe (2016) (154)
Tuberculosis elimination: theory and practice in Europe (2014) (153)
Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment (2002) (150)
Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions (2003) (145)
The EMBARC European Bronchiectasis Registry: protocol for an international observational study (2016) (144)
Chlamydophila pneumoniae. (2020) (144)
Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. (1990) (141)
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. (2000) (141)
Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. (1994) (138)
The receptor for urokinase‐plasminogen activator (1986) (138)
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? (1994) (138)
Atypical pathogens and respiratory tract infections (2004) (132)
Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate (1989) (131)
Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. (1991) (129)
A regulatory element that mediates co‐operation between a PEA3‐AP‐1 element and an AP‐1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. (1992) (129)
Electronic cigarettes: a task force report from the European Respiratory Society (2019) (129)
Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo (2000) (127)
Independent regulation of initiation and maintenance phases of Hoxa3 expression in the vertebrate hindbrain involve auto- and cross-regulatory mechanisms. (2001) (126)
A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny (2005) (124)
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (2016) (124)
The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients (2020) (123)
The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections. (2016) (121)
Through and beyond the wall: late steps in leukocyte transendothelial migration. (1997) (119)
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective (2013) (119)
Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. (2013) (118)
Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. (1999) (116)
How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan (2012) (116)
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. (2008) (115)
Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta (1988) (114)
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study (2020) (114)
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. (2001) (112)
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. (1996) (112)
MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. (2004) (112)
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. (1999) (111)
Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation. (1995) (111)
Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity (2005) (111)
Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract (1991) (110)
Urokinase‐receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. (1991) (110)
Hypomorphic Mutation of the TALE Gene Prep1 (pKnox1) Causes a Major Reduction of Pbx and Meis Proteins and a Pleiotropic Embryonic Phenotype (2006) (109)
An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. (1988) (109)
Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. (2002) (106)
The urokinase receptor. A cell surface, regulated chemokine (1999) (106)
Complement activation and endothelial perturbation parallel COVID-19 severity and activity (2020) (105)
In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. (1999) (105)
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. (2013) (104)
The Severe Asthma Network in Italy: Findings and Perspectives. (2019) (104)
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. (2000) (102)
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis (2015) (102)
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. (2005) (102)
Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. (1991) (101)
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use (2014) (100)
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. (2004) (98)
Proteomics Analysis of Nucleolar SUMO-1 Target Proteins upon Proteasome Inhibition* (2009) (98)
The urokinase receptor as an entertainer of signal transduction. (2009) (95)
Direct interaction of two homeoproteins, Homothorax and Extradenticle, is essential for EXD nuclear localization and function (2000) (95)
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. (1999) (94)
Electronic nicotine delivery systems (2015) (94)
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. (2010) (94)
The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. (2008) (94)
Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. (2000) (92)
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. (2000) (92)
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease. (2005) (91)
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients (2014) (91)
Urokinase/urokinase receptor and vitronectin/αvβ3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways (2001) (91)
Hoxb1 Enhancer and Control of Rhombomere 4 Expression: Complex Interplay between PREP1-PBX1-HOXB1 Binding Sites (2005) (91)
The urokinase receptor and regulation of cell surface plasminogen activation. (1990) (89)
Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization* (2002) (89)
Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate (1986) (88)
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019) (87)
Monomer–dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies (2007) (86)
Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and α2MRLRP genes (1996) (85)
Reliability of Nested PCR for Detection of Chlamydia pneumoniae DNA in Atheromas: Results from a Multicenter Study Applying Standardized Protocols (2002) (85)
Expression of Hoxa2 in rhombomere 4 is regulated by a conserved cross-regulatory mechanism dependent upon Hoxb1. (2007) (85)
Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β–SMAD3 pathway in non-small cell lung adenocarcinoma (2014) (84)
The urokinase/urokinase-receptor system and cancer invasion. (1995) (84)
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. (2020) (84)
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis (2021) (83)
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. (1993) (83)
Urokinase-dependent cell surface proteolysis and cancer. (1990) (83)
Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group. (2001) (83)
Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor. (1994) (82)
Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. (1991) (82)
Metalloproteases Cleave the Urokinase-Type Plasminogen Activator Receptor in the D1-D2 Linker Region and Expose Epitopes not Present in the intact Soluble Receptor (2002) (82)
Domain 1 of the urokinase receptor (uPAR) is required for uPAR‐mediated cell binding to vitronectin (2000) (82)
Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. (1986) (81)
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study. (2001) (79)
A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. (1995) (79)
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study (2020) (79)
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry (2019) (79)
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients (2018) (78)
N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. (1993) (77)
The urokinase receptor: Structure, regulation and inhibitor-mediated internalization (1994) (77)
A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. (1997) (77)
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. (1999) (76)
Aetiology of acute pharyngitis: the role of atypical bacteria. (2004) (76)
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. (2018) (76)
Prep1.1 has essential genetic functions in hindbrain development and cranial neural crest cell differentiation (2004) (76)
Community-acquired pneumonia related to intracellular pathogens (2016) (73)
The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis (2020) (73)
PAI‐1 inhibits urokinase‐induced chemotaxis by internalizing the urokinase receptor (2001) (73)
The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion (2004) (73)
The PBX-Regulating Protein PREP1 is present in different PBX-complexed forms in mouse (1999) (72)
Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. (1998) (72)
An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. (2005) (71)
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy. (2010) (71)
Successful Transplantation of Lungs From an Uncontrolled Donor After Circulatory Death Preserved In Situ by Alveolar Recruitment Maneuvers and Assessed by Ex Vivo Lung Perfusion (2016) (69)
Urokinase Plasminogen Activator Receptor Affects Bone Homeostasis by Regulating Osteoblast and Osteoclast Function (2007) (69)
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments (2020) (69)
Neutrophil elastase in bronchiectasis (2017) (68)
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients (2016) (67)
Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH (2013) (66)
Demonstration of Viable Chlamydia pneumoniae in Atherosclerotic Plaques of Carotid Arteries by Reverse Transcriptase Polymerase Chain Reaction (1999) (66)
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury (2010) (65)
Purification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcription (1994) (64)
Human urokinase gene is located on the long arm of chromosome 10. (1985) (64)
Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. (2009) (64)
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection (2008) (64)
Can CAP guideline adherence improve patient outcome in internal medicine departments? (2008) (63)
A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor. (1991) (63)
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. (2011) (63)
The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene (1988) (62)
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. (2021) (61)
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia (2009) (61)
Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis (2016) (60)
Clathrin and LRP-1-Independent Constitutive Endocytosis and Recycling of uPAR (2008) (59)
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones (2012) (59)
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. (2014) (59)
Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium (2013) (59)
Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD (2017) (58)
Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator. (1992) (57)
Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. (1994) (57)
Role of Atypical Bacteria and Azithromycin Therapy for Children With Recurrent Respiratory Tract Infections (2005) (56)
Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones. (2014) (56)
Glutamate-Dependent Activation of NF-κB During Mouse Cerebellum Development (1997) (56)
Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. (2009) (56)
Urokinase–urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication (2002) (56)
Cooperative Interactions between PBX, PREP, and HOX Proteins Modulate the Activity of the α2(V) Collagen (COL5A2) Promoter* (2000) (55)
Validation of Predictors of Adverse Outcomes in Hospital-Acquired Pneumonia in the ICU* (2013) (54)
Effects of Melatonin in Perimenopausal and Menopausal Women: Our Personal Experience (2005) (54)
Pulmonary embolism in a young pregnant woman with COVID-19 (2020) (54)
Integrative microbiomics in bronchiectasis exacerbations (2021) (54)
Characterization of PREP2, a paralog of PREP1, which defines a novel sub-family of the MEINOX TALE homeodomain transcription factors. (2002) (53)
Overexpression of PREP-1 in F9 Teratocarcinoma Cells Leads to a Functionally Relevant Increase of PBX-2 by Preventing Its Degradation* (2003) (52)
Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (2016) (52)
p160 Myb-Binding Protein Interacts with Prep1 and Inhibits Its Transcriptional Activity (2007) (52)
Compliance with anti-H1N1 vaccine among healthcare workers and general population. (2012) (52)
Defective T cell receptor/CD3 complex signaling in human type I diabetes (1994) (52)
The role of vaccination in preventing pneumococcal disease in adults. (2014) (51)
“Management of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies” (2020) (51)
Cytoplasmic Prep1 Interacts with 4EHP Inhibiting Hoxb4 Translation (2009) (51)
Regulation of urokinase‐type plasminogen activator expression in squamous‐cell carcinoma of the oral cavity (1993) (51)
Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2. (1992) (51)
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells (1987) (50)
Neurological Basis of AMP-Dependent Thermoregulation and its Relevance to Central and Peripheral Hyperthermia (2013) (50)
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro (2008) (49)
Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment (2020) (49)
Improving the TB case management: the International Standards for Tuberculosis care (2006) (49)
Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation (1999) (49)
Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. (2001) (49)
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016) (49)
Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection (2011) (48)
Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. (2002) (48)
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients (2020) (47)
Induction of HoxB transcription by retinoic acid requires actin polymerization. (2009) (47)
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. (2021) (47)
Chlamydia Pneumoniae Infection (1995) (47)
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia (2014) (47)
Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro. (1992) (46)
Prep1 Deficiency Induces Protection from Diabetes and Increased Insulin Sensitivity through a p160-Mediated Mechanism (2008) (46)
Assessment of Severity of ICU-Acquired Pneumonia and Association With Etiology (2014) (46)
Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. (1996) (46)
Increased Mycobacterium tuberculosis growth in HIV‐1‐infected human macrophages: role of tumour necrosis factor‐α (2001) (46)
Bedaquiline and delamanid in tuberculosis (2015) (46)
Azithromycin use in patients with cystic fibrosis (2015) (45)
Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis (2014) (45)
Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins. (1988) (45)
The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine) (2014) (44)
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury (2010) (44)
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis (2014) (44)
The urokinase receptor is overexpressed in the AIDs dementia complex and other neurological manifestations (2004) (44)
Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study (2017) (44)
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. (2014) (43)
Epidemiology of Chlamydia pneumoniae. (1998) (43)
Prep1 (pKnox1)‐deficiency leads to spontaneous tumor development in mice and accelerates EμMyc lymphomagenesis: A tumor suppressor role for Prep1 (2010) (43)
A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer. (2017) (43)
Myb-Binding Protein 1A (MYBBP1A) Is Essential for Early Embryonic Development, Controls Cell Cycle and Mitosis, and Acts as a Tumor Suppressor (2012) (43)
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. (2020) (42)
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity. (2007) (42)
Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. (2004) (42)
Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index (2013) (42)
Involvement of Prep1 in the αβ T-Cell Receptor T-Lymphocytic Potential of Hematopoietic Precursors (2005) (42)
An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory health. (2013) (42)
Inhibition of NF-KB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1 (1995) (42)
Psychopathological Dimensions of Harassment in the Workplace (Mobbing) (2007) (41)
Strategic Targets of Essential Host-Pathogen Interactions (2005) (41)
HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. (2005) (41)
Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia (2018) (41)
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group (2011) (41)
1B/(−)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 (2012) (41)
Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response (2015) (40)
A comprehensive approach to lung function in bronchiectasis. (2018) (40)
COPD and Bronchiectasis: Phenotype, Endotype or Co-morbidity? (2014) (40)
Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. (2006) (40)
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia (2012) (40)
Prognostic assessment in COPD without lung function: the B-AE-D indices (2016) (39)
De-escalation therapy among bacteraemic patients with community-acquired pneumonia. (2015) (39)
Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study. (1999) (39)
The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells (2010) (38)
The role of antibiotics in asthma (2007) (38)
The urokinase receptor and the regulation of cell proliferation (2005) (38)
Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial (2015) (38)
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis (2020) (37)
Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC) (2011) (37)
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. (2011) (37)
Effect of Substance P on uterine mast cell cytokine release during the reproductive cycle (1995) (37)
Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability (2011) (36)
A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis. (2006) (36)
Acute exacerbations of COPD: risk factors for failure and relapse (2017) (36)
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines (2011) (36)
Chlamydia pneumoniae and Mycoplasma pneumoniae. (2005) (35)
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation (2014) (35)
High‐flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: A pilot randomized controlled trial (2018) (35)
Signal Integration and Coincidence Detection in the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Cascade (2011) (35)
Switching treatments in COPD: implications for costs and treatment adherence (2015) (35)
Structure and Function of the Urokinase Receptor (1999) (35)
Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study (2015) (34)
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease (2004) (34)
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases (2014) (34)
Use of Antimicrobial Agents for Community-Acquired Lower Respiratory Tract Infections in Hospitalised Children (2001) (34)
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) (2020) (33)
Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase (2010) (33)
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. (2021) (33)
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes. (2013) (33)
Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. (1996) (33)
Therapy with proton‐pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD (2016) (33)
Adherence to asthma treatments: ‘we know, we intend, we advocate’ (2015) (33)
Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing (2013) (33)
The clinical and integrated management of COPD. (2014) (33)
Pneumonia in frail older patients: an up to date (2012) (33)
Quality standards for the management of bronchiectasis in Italy: a national audit (2016) (32)
Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. (1997) (32)
Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor. (1984) (32)
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis (2018) (32)
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (2018) (32)
Bronchodilators modulate inflammation in chronic obstructive pulmonary disease subjects. (2012) (32)
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy (2017) (32)
Detection of Chlamydiae pneumoniae but Not Helicobacter pylori DNA in Atherosclerosis Plaques (2003) (32)
Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity? (2016) (32)
Antibiotics as immunomodulant agents in COPD. (2012) (32)
Chlamydia pneumoniae and asthma (1998) (32)
Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. (1993) (31)
Two family outbreaks of Chlamydia pneumoniae infection. (1994) (31)
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration (2017) (31)
Collagen Degradation and Formation Are Elevated in Exacerbated COPD Compared With Stable Disease (2018) (31)
Clast4, the murine homologue of human eIF4E-Transporter, is highly expressed in developing oocytes and post-translationally modified at meiotic maturation. (2006) (30)
ERS/WHO Tuberculosis Consilium: reporting of the initial 10 cases (2013) (30)
The biology of pulmonary exacerbations in bronchiectasis (2019) (30)
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections. (2020) (30)
The urokinase receptor and cell migration. (1996) (30)
Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development (1998) (30)
Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. (1994) (30)
Chlamydia pneumoniae respiratory infections. (2000) (30)
Hemostatic alterations in COVID-19 (2020) (30)
PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17B/C. (1998) (29)
Pertussis Toxin B-Oligomer Suppresses IL-6 Induced HIV-1 and Chemokine Expression in Chronically Infected U1 Cells via Inhibition of Activator Protein 11 (2006) (29)
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice (2003) (29)
Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-α mRNA in rat mast cells: evidence of a receptor-independent mechanism (1997) (29)
Echocardiography in pulmonary arterial hypertension: An essential tool. (2007) (29)
Treatment strategies for asthma: reshaping the concept of asthma management (2020) (29)
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia (2015) (29)
Burden of community-acquired pneumonia in Italian general practice (2013) (28)
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19 (2021) (28)
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice (2007) (28)
Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. (2010) (28)
Biomarkers in lower respiratory tract infections. (2010) (28)
Identification of 3',5'-cyclic adenosine monophosphate-inducible nuclear factors binding to the human urokinase promoter in mouse Sertoli cells. (1993) (28)
Recombinant protein‐based ELISA and immuno‐cytochemical assay for the diagnosis of SARS† (2005) (28)
The European Union standards for tuberculosis care: do they need an update? (2014) (28)
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR). (2015) (28)
Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study (2014) (28)
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs. (2016) (28)
Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis (2020) (28)
The Cancer Degradome (2009) (27)
Pneumococcal vaccination and chronic respiratory diseases (2017) (27)
Collaborative multidisciplinary workshop report: detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae. (2000) (27)
Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. (2001) (27)
Expression of Hox cofactor genes during mouse ovarian follicular development and oocyte maturation. (2004) (27)
A systematic review on the impact of appropriate versus inappropriate initial antibiotic therapy on the outcomes of patients with severe bacterial infections. (2020) (27)
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis (2019) (26)
Outbreak of Chlamydia pneumoniae infection in former injection-drug users. (1994) (26)
Prevalence and incidence of bronchiectasis in Italy (2020) (26)
The Growth Factor Module of Urokinase is the Binding Sequence for Its Receptor (1987) (26)
Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure (2019) (25)
An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients (2003) (25)
Down syndrome fibroblasts and mouse Prep1-overexpressing cells display increased sensitivity to genotoxic stress (2010) (25)
Blood eosinophils predict inhaled fluticasone response in bronchiectasis (2020) (25)
uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition. (2008) (25)
Detection of Respiratory Viruses and Atypical Bacteria in Children's Tonsils and Adenoids (2007) (25)
NF‐κB‐mediated regulation of urokinase gene expression by PMA and TNF‐α in human A549 cells (1996) (25)
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey (2013) (25)
In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm (2018) (24)
COVID‐19 in lung transplant recipients: A case series from Milan, Italy (2020) (24)
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1. (1995) (24)
Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study (2020) (24)
The evidence on tiotropium bromide in asthma: from the rationale to the bedside (2017) (24)
AMP-Dependent Hypothermia Affords Protection from Ischemic Brain Injury (2013) (24)
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis (2018) (24)
A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene. (1991) (24)
Doctor-patient relationship: a resource to improve respiratory diseases management. (2012) (24)
Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998. (1999) (24)
Serum levels of hyaluronic acid are associated with COPD severity and predict survival (2019) (24)
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia. (2011) (24)
Prep1 Directly Regulates the Intrinsic Apoptotic Pathway by Controlling Bcl-XL Levels (2008) (24)
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study (2018) (24)
Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. (1998) (24)
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) (2020) (24)
Delivering Antibacterials to the Lungs (2002) (24)
PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice (2013) (23)
Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study (2014) (23)
The burden of sinus disease in cystic fibrosis lung transplant recipients (2018) (23)
Follicle-stimulating hormone and cyclic AMP induce transcription from the human urokinase promoter in primary cultures of mouse Sertoli cells. (1990) (23)
No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. (1996) (23)
COVID-19 multidisciplinary high dependency unit: the Milan model (2020) (23)
Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection (2020) (23)
Hospital Admission Decision for Patients with Community-Acquired Pneumonia (2013) (23)
Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables (2021) (23)
Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development. (2016) (23)
ICU-Acquired Pneumonia With or Without Etiologic Diagnosis: A Comparison of Outcomes* (2013) (23)
An international perspective on hospitalized patients with viral community-acquired pneumonia (2018) (22)
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) (2021) (22)
Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells. (1992) (22)
Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis (2018) (22)
Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity (1996) (22)
Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study. (2022) (22)
Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy. (2017) (22)
The role of urokinase‐type plasminogen activator (uPA)/uPA receptor in HIV‐1 infection (2003) (22)
Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome (2020) (22)
Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience (2021) (22)
Incidence of community-acquired pneumonia caused byChlamydia pneumoniae in Italian patients (1993) (21)
Pknox1/Prep1 Regulates Mitochondrial Oxidative Phosphorylation Components in Skeletal Muscle (2013) (21)
Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells (1995) (21)
Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe (2012) (21)
Clinical applications of azithromycin microspheres in respiratory tract infections (2007) (21)
Macrolide and occult infection in asthma (2004) (21)
Healthcare workers and influenza vaccination: an ERS-ESCMID Web-based survey. (2011) (21)
Protein Kinase C-dependent in VivoPhosphorylation of Prourokinase Leads to the Formation of a Receptor Competitive Antagonist* (1998) (21)
Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. (2014) (21)
Value of short-course antimicrobial therapy in community-acquired pneumonia. (2005) (21)
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration (2018) (21)
Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner. (2008) (21)
ChIP-Seq and RNA-Seq Analyses Identify Components of the Wnt and Fgf Signaling Pathways as Prep1 Target Genes in Mouse Embryonic Stem Cells (2015) (20)
Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination. (2017) (20)
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults (2020) (20)
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE st (2015) (20)
cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain (2000) (20)
Future directions for the ERS: Presidential plans (2013) (20)
Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study (2013) (20)
Limitations to providing adult cystic fibrosis care in Europe: Results of a care centre survey. (2017) (20)
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia (2013) (19)
An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health (2013) (19)
Genuair® Usability Test: Results of a National Public Survey of the Elderly (2016) (19)
Azithromycin and lower respiratory tract infections (2005) (19)
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia (2012) (19)
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity (2021) (19)
Chronic obstructive pulmonary disease guidelines in Europe: a look into the future (2018) (19)
Human plasminogen activators. Genes and proteins structure. (1986) (19)
Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line. (1992) (19)
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response (2022) (19)
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis (2018) (18)
Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin‐mediated cell adhesion (2007) (18)
In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia (2019) (18)
Glutamate-dependent activation of NF-kappaB during mouse cerebellum development. (1997) (18)
The role of biomarkers in low respiratory tract infections. (2012) (18)
A Transcription-dependent Micrococcal Nuclease-resistant Fragment of the Urokinase-type Plasminogen Activator Promoter Interacts with the Enhancer* (2007) (18)
Chlamydia pneumoniae detection in atherosclerotic plaques in Italy. (2000) (18)
Adrenomedullin optimises mortality prediction in COPD patients. (2015) (18)
Use of venovenous extracorporeal membrane oxygenation as a bridge to urgent lung transplantation in a case of acute respiratory failure. (2009) (18)
PMA‐induced down‐regulation of the receptor for α2‐macroglobulin in human U937 cells (1995) (18)
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI (2020) (17)
Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens. (1997) (17)
The Plasminogen Activator System in Extracellular Matrix Degradation (1992) (17)
PREP1 tumor suppressor protects the late-replicating DNA by controlling its replication timing and symmetry (2018) (17)
Tissue-type plasminogen activator gene is on chromosome 8. (1986) (17)
Chlamydia pneumoniae: crossing the barriers? (2004) (17)
In vivo analysis of the state of the human uPA enhancer following stimulation by TPA (1999) (17)
Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression. (2020) (17)
Differential DNA damage signalling and apoptotic threshold correlate with mouse epiblast-specific hypersensitivity to radiation (2015) (17)
Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultrasound? (2020) (17)
Does Improving Exercise Capacity and Daily Activity Represent the Holistic Perspective of a New COPD Approach? (2015) (17)
Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003-2004). (2009) (16)
Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study (2014) (16)
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review (2019) (16)
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells (2007) (16)
Separation and characterization of nonphosphorylated and serine-phosphorylated urokinase. Catalytic properties and sensitivity to plasminogen activator inhibitor type 1. (1992) (16)
How to choose the duration of antibiotic therapy in patients with pneumonia (2015) (16)
Proteome Investigation of Rat Lungs Subjected to Ex Vivo Perfusion (EVLP) (2018) (16)
Age at symptom onset and distribution by sex and symptoms in patients sensitized to different allergens (1998) (16)
A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts (2007) (16)
The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene. (1988) (15)
100 years of respiratory medicine: pneumonia. (2007) (15)
Atypical bacteria in adenoids and tonsils of children requiring adenotonsillectomy (2010) (15)
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement (2018) (15)
Atypical pathogens and asthma: can they influence the natural history of the disease? (2001) (15)
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients (2020) (15)
[Pneumococcal vaccination in adults: recommendations from the Italian Society of Respiratory Medicine (SIMeR) and the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI)]. (2014) (15)
Repeteability of Circulating Eosinophil Measures and Inhaled Corticosteroids Effect in Bronchiectasis. A Post Hoc Analysis of a Randomized Clinical Trial. (2020) (15)
Chest physiotherapy in European patients with bronchiectasis: Data from the EMBARC registry (2017) (15)
Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study (2015) (15)
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials. (2020) (15)
Incidental Chest Radiographic Findings in Adult Patients With Acute Cough (2012) (15)
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy (2020) (15)
Oct-1 specifically binds the UEF4 site of the human AP1-regulated urokinase enhancer. (2000) (14)
Molecular mechanisms of protease-mediated tumor invasiveness. (1993) (14)
Comparison of different conditions for DNA extraction in sputum - a pilot study (2019) (14)
Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (2020) (14)
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach (2017) (14)
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. (2007) (14)
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication (2013) (14)
Neucleotide sequence of a full length cDNA clone encoding for β-tubulin of the sea urchin Paracentrotus Lividus (1989) (14)
Myb-Binding Protein Interacts with Prep 1 and Inhibits Its Transcriptional Activity † (2007) (14)
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. (2009) (14)
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections. (2006) (14)
Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study* (2019) (13)
Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study). (2009) (13)
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer. (2009) (13)
Community-acquired pneumonia: role of atypical organisms. (2001) (13)
Transcriptional Regulation of the Murine Urokinase-type Plasminogen Activator Gene in Skeletal Myoblasts (1999) (13)
Detailed stratified GWAS analysis for severe COVID-19 in four European populations (2022) (13)
In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms (2018) (13)
Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study. (2017) (13)
Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. (2018) (13)
Prep1 prevents premature adipogenesis of mesenchymal progenitors (2017) (13)
Serine phosphorylation of biosynthetic pro‐urokinase from human tumor cells (1990) (13)
Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections (2003) (13)
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy (2020) (13)
Interactive Monitoring Service and COPD: Is it Possible to Reduce Nonadherence? (2015) (13)
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context (2019) (13)
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis. (2005) (13)
The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. (2006) (13)
The receptor for the plasminogen activator of urokinase type is up‐regulated in transformed rat thyroid cells (1992) (13)
Tumorigenesis by Meis1 overexpression is accompanied by a change of DNA target-sequence specificity which allows binding to the AP-1 element (2015) (13)
New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations (2021) (13)
Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy (2017) (13)
Characterization of UEF-4, a DNA-binding Protein Required for Transcriptional Synergism between Two AP-1 Sites in the Human Urokinase Enhancer* (1997) (13)
Brain Ischemic Preconditioning Does Not Require PARP-1 (2010) (12)
Hypoactivity of the Hypothalamo-Pituitary-Adrenal Axis in Victims of Mobbing: Role of the Subjects’ Temperament and Chronicity of the Work-Related Psychological Distress (2009) (12)
Early pulmonary function and mid‐term outcome in lung transplantation after ex‐vivo lung perfusion – a single‐center, retrospective, observational, cohort study (2020) (12)
Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR). (2006) (12)
Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma. (2015) (12)
Purification of the Prep1 interactome identifies novel pathways regulated by Prep1 (2007) (12)
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis. (2019) (12)
IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes (2018) (12)
Clinical Use and Barriers of Thoracic Ultrasound: A Survey of Italian Pulmonologists (2018) (12)
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia. (2009) (12)
Individualizing duration of antibiotic therapy in community-acquired pneumonia. (2017) (12)
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis (2007) (12)
NF-kappa B-mediated regulation of urokinase gene expression by PMA and TNF-alpha in human A549 cells. (1996) (12)
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline (2020) (12)
The European Respiratory Society plans its future: the 2013–2018 strategic plan (2014) (12)
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis. (2018) (11)
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. (2009) (11)
A recombinant pro-urokinase derived mutant missing the growth factor-like domain does not bind to its receptor (1990) (11)
Respiratory diseases in the world: one voice “united for lung health” (2014) (11)
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study. (2021) (11)
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia. (2018) (11)
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics (2016) (11)
Severe asthma: One disease and multiple definitions (2021) (11)
Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial (2022) (11)
Therapeutic approach to respiratory infections in lung transplantation (2014) (11)
State of the art review: management of bronchiectasis in adults (2015) (11)
review pneumonia in adults in Europe : a literature Risk factors for community-acquired (2013) (11)
Potential role of antibiotics in the treatment of asthma. (2004) (11)
In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis. (2018) (11)
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1. (2015) (11)
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance (2012) (11)
Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease. (2009) (11)
Reduction of Prep1 Levels Affects Differentiation of Normal and Malignant B Cells and Accelerates Myc Driven Lymphomagenesis (2012) (11)
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia (2016) (11)
Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study. (2020) (11)
Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques. (2019) (11)
New pathogens for respiratory infections (1996) (11)
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments (2021) (11)
Incidence of Chlamydia pneumoniae Infection in Vertically HIV-1 Infected Children (1998) (11)
Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections. (2001) (11)
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries (2017) (11)
Efferocytosis: another function of uPAR. (2009) (10)
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study (2016) (10)
Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study (2019) (10)
Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis. (2013) (10)
Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: a pilot study. (2012) (10)
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol (2018) (10)
BamHI RFLP linked to the human urokinase gene. (1985) (10)
Mixed community-acquired lower respiratory tract infections (2007) (10)
Cytosolic Sequestration of Prep1 Influences Early Stages of T Cell Development (2008) (10)
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage. (2014) (10)
Prep1 (pKnox1) Regulates Mouse Embryonic HSC Cycling and Self-Renewal Affecting the Stat1-Sca1 IFN-Dependent Pathway (2014) (10)
Trophoblast giant cells express NF-kappa B2 during early mouse development. (1999) (10)
Nuclear actin polymerization from faster growing ends in the initial activation of Hox gene transcription (2013) (10)
and NF-kB activation: closing the loop on the papillary thyroid cancer trilogy (2011) (10)
Mechanisms and Management of COPD Exacerbations (2000) (10)
The prevalence of sleep impairments and predictors of sleep quality among patients with asthma (2020) (10)
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study (2021) (9)
Chlamydia pneumoniae and COPD exacerbation [2] (multiple letters) (2002) (9)
In silico docking of urokinase plasminogen activator and integrins (2008) (9)
Intraoperative extracorporeal membrane oxygenation for lung transplantation in cystic fibrosis patients: Predictors and impact on outcome. (2020) (9)
Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation (2017) (9)
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis (2021) (9)
Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study (2020) (9)
Characterization of UEF-4, a DNA-binding protein required for transcriptional synergism between two AP-1 sites in the human urokinase enhancer. (1997) (9)
Public awareness on cystic fibrosis: results from a national pragmatic survey (2015) (9)
Sympatho–Vagal Dysfunction in Patients with End-Stage Lung Disease Awaiting Lung Transplantation (2020) (9)
The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1- Hoxa9 Leukemogenesis (2014) (9)
Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation. (2016) (9)
Emerging pathogens of community-acquired pneumonia: a two-year prospective study. (1995) (9)
Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection (2017) (8)
An update on the pharmacotherapeutic management of lower respiratory tract infections (2017) (8)
Cardiovascular complications in patients with community-acquired pneumonia (2017) (8)
Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation. (2021) (8)
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life☆ (2021) (8)
Urinary levels of urokinase‐type plasminogen activator and its receptor in the detection of bladder carcinoma (2003) (8)
Comprar The Cancer Degradome · Proteases and Cancer Biology | Edwards, Dylan | 9780387690568 | Springer (2009) (8)
Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens. (2001) (8)
[Tako-tsubo syndrome in a young man with amyotrophic lateral sclerosis. A case report]. (2011) (8)
Purification and Characterization of a DNA-Binding Recombinant PREP1:PBX1 Complex (2015) (8)
1 B / ( 2 ) IRE DMT 1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NFk B / RelA Acetylation at Lys 310 (2012) (8)
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study (2022) (8)
New Insights into Cooperative Binding of Homeodomain Transcription Factors PREP1 and PBX1 to DNA (2017) (8)
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations (2022) (8)
The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study (2019) (8)
Airway Obstruction and Bronchodilator Responsiveness in Adults With Acute Cough (2012) (8)
Requirements Engineering Meets Physiotherapy: An Experience with Motion-Based Games (2013) (8)
Knowledge and attitudes on influenza vaccination among Italian physicians specialized in respiratory infections: an Italian Respiratory Society (SIP/IRS) web-based survey. (2018) (8)
GRACE and the development of an education and training curriculum. (2012) (8)
A 13-year-old female with shortness of breath and pleuritic chest pain (2006) (8)
The flexibility of a homeodomain transcription factor heterodimer and its allosteric regulation by DNA binding (2016) (8)
Role of the Oral Beta-Lactams in the Treatment of Exacerbations of Chronic Bronchitis: Critical Analysis and Therapeutic Recommendations (2010) (8)
Mapping the native interaction surfaces of PREP1 with PBX1 by cross-linking mass-spectrometry and mutagenesis (2020) (8)
Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1). (2019) (8)
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey. (2017) (8)
Human genes and diseases (1986) (8)
The role of azithromycin in treating children with community-acquired pneumonia (1994) (8)
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores. (2012) (8)
Therapies in development for community-acquired pneumonia (2002) (8)
Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis (2020) (7)
Lung recruitability of COVID-19 pneumonia in patients undergoing helmet CPAP (2020) (7)
Role of atypical bacteria in children undergoing tonsillectomy because of severely recurrent acute tonsillopharyngitis (2008) (7)
Binding of Sp 1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC 3 cells (2002) (7)
Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients (2022) (7)
Bronchiectasis: an update (2009) (7)
Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature (2020) (7)
Fluticasone propionate/formoterol: a fixed-combination therapy with flexible dosage. (2014) (7)
Clinical features of Chlamydia pneumoniae acute respiratory infection (1996) (7)
Newer antibiotics for the treatment of respiratory tract infections (2004) (7)
Manifesto on the Value of Adult Immunization: “We Know, We Intend, We Advocate” (2021) (7)
The management of asthma in the phenotype and biomarker era: The proposal of a new diagnostic-therapeutic model (2016) (7)
Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning? (2014) (7)
International perspective on the new 2019 ATS/IDSA CAP guideline – a critical appraisal by a global expert panel (2020) (7)
Nasopharyngeal Microbiota Analysis in Healthy and Otitis-prone Children (2020) (7)
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study (2021) (7)
TB or not TB: update from the ERS Respiratory Infection Assembly 10 (2010) (7)
Adults with cystic fibrosis and pulmonologists: new training needed to recruit future specialists (2019) (7)
Noninvasive methods for the diagnosis of pneumonia (1997) (7)
XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine (2015) (7)
Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy (2017) (7)
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide (2018) (7)
Consensus document on controversial issues for the treatment of hospital-associated pneumonia. (2010) (7)
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry (2020) (6)
The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry (2018) (6)
Possible stage‐specific function of NF‐κB during pre‐B cell differentiation (1998) (6)
The receptor for human urokinase: a potential target for anti-invasive and anti-metastatic therapy. (1990) (6)
When and how ruling out cystic fibrosis in adult patients with bronchiectasis (2018) (6)
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia (2009) (6)
European Respiratory roadmap. Recommendations for the future of respiratory medicine. (2011) (6)
Prep1 (pKnox1) transcription factor contributes to pubertal mammary gland branching morphogenesis. (2018) (6)
Chlamydia pneumoniae and COPD exacerbation. Authors' reply (2002) (6)
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series. (2022) (6)
Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study (2022) (6)
Erratum A Pbx 1-dependent genetic and transcriptional network regulates spleen ontogeny (2005) (6)
193 In vitro synergistic effect of NaCl and antibiotics against P. aeruginosa from cystic fibrosis patients (2017) (6)
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? (2015) (6)
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? (2017) (6)
Heated Humidifi ed High-Flow Nasal Oxygen in Adults Mechanisms of Action and Clinical Implications (2015) (6)
Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review (2020) (6)
Production of urokinase-type plasminogen activator by normal and transformed rat thyroid cells in culture. (1989) (6)
Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations. (2010) (5)
Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia (2017) (5)
The in vitro effects of ceftibuten on the host defense mechanism. (1994) (5)
A Key Molecule Dictating and Regulating Surface Plasmin Formation : The Receptor for Urokinase Plasminogen Activator (1990) (5)
Chlamydia pneumoniae and acute aortic syndrome: a call for a multi-institutional study. (2008) (5)
Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients (2022) (5)
Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells. (2006) (5)
Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies (2021) (5)
Drug-resistant pathogens in community-acquired pneumonia (2015) (5)
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center (2022) (5)
Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab (2021) (5)
Better comfort and dyspnea scores with high-flow nasal cannula (HFNC) vs standard oxygen (SO) during breaks off noninvasive ventilation (NIV) (2015) (5)
Protease–Antiprotease Imbalance in Bronchiectasis (2021) (5)
Phosphatidylinositol 5-phosphate 4-kinase (2012) (5)
Repeteability of Circulating Eosinophil Measures and Inhaled Corticosteroids Effect in Bronchiectasis. A Post Hoc Analysis of a Randomized Clinical Trial (2020) (5)
Detection and Classification of Bronchiectasis Through Convolutional Neural Networks (2021) (5)
Nasal polyps impact in severe asthma patients: evidences from the SANI (2020) (5)
Definition and aetiology of non-CF bronchiectasis. (2013) (5)
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment (2021) (5)
Achoo, achis, ATCHIN! Vaccine you… (2018) (5)
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis. (2021) (5)
The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion (1994) (5)
33 The urokinase-sensitive region of the urokinase receptor is responsible for its potent chemotactic activity (1997) (5)
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. (2004) (5)
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry (2020) (5)
Bronchiectasis and inhaled tobramycin: A literature review. (2022) (5)
Impact of chronic bronchial infection on the lungs and beyond. (2013) (5)
Variability in access and referral to pulmonary rehabilitation in European bronchiectasis patients enrolled in the EMBARC registry (2018) (4)
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis. (2020) (4)
The challenge of breathlessness in the detection of pulmonary hypertension (2012) (4)
Preliminary Data on Chlamydia pneumoniae Seroprevalence in HIV‐1 Infected Children (1993) (4)
Lessons learnt in Europe on tuberculosis surveillance, outbreaks and BCG vaccination in 2011 (2013) (4)
The Role of Prep1 in the Regulation of Mesenchymal Stromal Cells (2019) (4)
[Echocardiography and pulmonary arterial hypertension]. (2007) (4)
Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside (2017) (4)
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study (2022) (4)
Mucormycosis in CAPA, a Possible Fungal Super-Infection (2021) (4)
Sex differences in bronchiectasis patient characteristics: an analysis of the EMBARC cohort (2018) (4)
A randomised placebo-controlled dose finding study of tobramycin inhalation powder (TIP) in patients with bronchiectasis (BE) and pulmonary P. aeruginosa Pa) infection (iBEST-1) (2018) (4)
Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department (2022) (4)
The transcription factor Prep1 controls hepatic insulin sensitivity and gluconeogenesis by targeting nuclear localization of FOXO1. (2016) (4)
Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey. (2016) (4)
Antibiotics and the Lung (2004) (4)
Safety and feasibility of physiotherapy in ICU-admitted severe COVID-19 patients: an observational study. (2022) (4)
Prevention and treatment of exacerbations of non-CF bronchiectasis. (2013) (4)
Determinants of quality of life in bronchiectasis using the quality of life bronchiectasis (QOL-B) questionnaire: data from the EMBARC registry (2018) (4)
Recruitment manoeuvres dislodge mucus towards the distal airways in an experimental model of severe pneumonia (2019) (4)
Acute bronchitis: aetiology and treatment. (2013) (4)
A non-catalytic, human urokinase plasminogen activator derivative produced by mouse cells has full receptor binding activity (1991) (4)
Telithromycin in lower respiratory tract infections. (2006) (4)
u-PA and cell migration: urokinase receptor as a ligand for a chemotactic G-protein-coupled receptor. (2001) (4)
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) (2015) (4)
Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study (2020) (4)
Identification and characterization of cytotoxic amyloid-like regions in human Pbx-regulating protein-1. (2020) (4)
Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry (2018) (4)
A novel device for the prevention of airborne infections (1997) (4)
The genetics and the molecular functions of the PREP1 homeodomain transcription factor. (2018) (4)
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2017) (4)
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases (2022) (4)
Characterization of the Regulatory Region of the Zebrafish Prep1.1 Gene: Analogies to the Promoter of the Human PREP1 (2010) (3)
A surface receptor for urokinase plasminogen activator: a link between the cytoskeleton and the extracellular matrix (1988) (3)
Indicator condition-guided HIV testing in Europe: a step forward to HIV control (2013) (3)
Antibiotic therapy and prophylaxis in COPD (2007) (3)
The association between gastro-oesophageal reflux and exacerbations of bronchiectasis: data from the EMBARC registry (2017) (3)
Administrative databases and clinical governance: The case of COPD (2019) (3)
Chronic obstructive pulmonary disease in the elderly: identifying the knowledge gaps to support research and clinical practice guidelines (2011) (3)
ACE2 expression and localization are regulated by CFTR: implications beyond cystic fibrosis (2021) (3)
What is the best technique to extract bacterial DNA from sputum? (2018) (3)
Amyloid-like Prep1 peptides exhibit reversible blue-green-red fluorescence in vitro and in living cells. (2021) (3)
Effects of bilateral lung transplantation on cardiac autonomic modulation and cardiorespiratory coupling: a prospective study (2021) (3)
Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy. (2017) (3)
Differential DNA damage signalling and apoptotic threshold correlate with mouse epiblast-specific hypersensitivity to radiation (2015) (3)
Current Management Of Patients Hospitalized With Community-Acquired Pneumonia Across Europe (2010-2011): Assessment Of Clinical Practice Patterns And Real-Life Effectiveness Of Antibiotics (REACH Study) (2012) (3)
Separation and characterization of non-phosphorylated and serine-phosphorylated human urokinase. Catalytic properties and sensitivity to PAI-1 (1992) (3)
INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW (2018) (3)
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF. (2010) (3)
Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP (2020) (3)
Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study (2021) (3)
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID‐19? (2021) (3)
Diagnostic Value of Endotracheal Aspirates Sonication on Ventilator-Associated Pneumonia Microbiologic Diagnosis (2017) (3)
Innovation in lung health research--a Copernican revolution? (2013) (3)
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey. (2021) (3)
Guidelines and management of hospitalized patients with community-acquired pneumonia: the Italian experience of the FASTCAP study (2013) (3)
Immune Checkpoints Expression in Chronic Lung Allograft Rejection (2021) (3)
Have guidelines for the management of community-acquired pneumonia influenced outcomes? (2003) (3)
Erratum: The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury (Cell Death and Disease (2010) 1 (e107) DOI: 10.1038/cddis.2010.88) (2010) (3)
Chlamydia pneumoniae: Clinical Characteristics of Acute Respiratory Infections (1999) (3)
What is important for people with NTM? An EMBARC-ELF patient survey (2020) (3)
PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells. (1995) (3)
Nuclear levels of NF‐κB correlate with syncytium‐forming capacity of 8e51 cells, expressing a defective HIV virus (1997) (3)
Lung Diseases: Chronic Respiratory Infections (2018) (3)
Primary ciliary dyskinesia in adults with bronchiectasis: Data from the Embarc registry (2018) (3)
In‐vitro analysis of a novel ‘add‐on’ silicone cuff to improve sealing properties of tracheal tubes (2018) (2)
Right Ventricle Dysfunction in Patients With Adult Cystic Fibrosis Enlisted for Lung Transplant. (2020) (2)
Airway clearance techniques in patients with bronchiectasis. Data from the EMBARC Registry (2020) (2)
Role of Macrolides as Immunomodular Agents (2006) (2)
Incidence and prevalence of Chlamydia pneumoniae infection in COAD patients (1992) (2)
Textbook of respiratory and critical care infections (2015) (2)
Pneumonia in nursing home patients: is it time for a specific therapeutic strategy? (2013) (2)
Time to active sitting position: One-year findings from a temporary COVID-19 intensive care unit (2022) (2)
Virus-bacteria interactions in COPD exacerbations. (2013) (2)
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement (2021) (2)
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey (2020) (2)
New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC) (2019) (2)
Bronchiectasis in 2016: advances in our understanding. (2016) (2)
The Isoform GC1f of the Vitamin D Binding Protein Is Associated with Bronchiectasis Severity (2021) (2)
The management of patients with community-acquired pneumonia beyond antibiotic therapy. (2012) (2)
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy (2021) (2)
Reaching the golden milestone. The 2013 ERS Dublin summit: preparing the road to Rome (2013) (2)
Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry (2019) (2)
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment (2021) (2)
Short Duration of Antibiotic Therapy in Hospitalized Patients with Community-Acquired Pneumonia: Results from the CAPO International Cohort Study (2017) (2)
A distinct metabolic profile associated with a fatal outcome in COVID-19 patients during early epidemic in Italy (2021) (2)
SEVERE ASTHMA: ONE DISEASE MANY DEFINITIONS (2019) (2)
Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease (2020) (2)
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study (2022) (2)
Chronic bronchial infection/colonisation: aetiology and mechanisms. (2013) (2)
Emerging antibacterial and antiviral drugs for treating respiratory tract infections (2018) (2)
Cardiovascular side-effects of common antibiotics (2020) (2)
Microbial Dysregulation of the 'Lung-Gut' Axis in High-Risk Bronchiectasis (2021) (2)
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation (2023) (2)
“Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning?” Francesco Blasi and Brian Ward. Eur Respir J 2014; 44: 585–588. (2015) (2)
Early acute rejection after lung transplantation mimicking viral pneumonia in the middle of COVID-19 pandemic: A case report (2020) (2)
Site of care and multidisciplinary approach (2018) (2)
Hospital-acquired pneumonia (2005) (2)
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome (2022) (2)
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review (2022) (2)
Chlamydia pneumoniae pneumonia: role of new macrolides. (1995) (2)
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis (2022) (2)
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (2016) (2)
Ventricular pacemaker lead in the left hemithorax: Mechanisms and evidence‐based management of a late‐onset hazardous complication (2021) (2)
High-Sensitivity Cardiac Troponin T and the Diagnosis of Cardiovascular Disease in the Emergency Room: The Importance of Combining Cardiovascular Biomarkers with Clinical Data (2022) (2)
405 Myopericarditis after SARS-CoV-2 MRNA vaccination: casual or causal relationship? (2021) (2)
Thymomodulin stimulates phagocytosis in vitro by rat macrophages and human polymorphonuclear cells. (1993) (2)
The urokinase receptor in hematopoietic stem cells mobilization. (2011) (2)
Respiratory infections management: Still a challenge. (2015) (2)
Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia (2012) (2)
Protein chemical characterization of the cellular receptor for urokinase-type plasminogen activator (1989) (2)
Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization. (2005) (2)
Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry (2018) (2)
Diagnosis and Initial Investigation of Bronchiectasis (2021) (2)
Automated, PCR-RFLP genotyping of the urokinase gene. (2000) (2)
Purification of a Single-Chain Urokinase Precursor from A431 Human Epidermoid Carcinoma Cells by Monoclonal Antibody Immunoaffinity Chromatography (1985) (2)
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study (2014) (2)
Determinants of survival in the European Bronchiectasis Registry(EMBARC) (2019) (1)
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over (2022) (1)
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy (2021) (1)
How to Identify Causes and Predisposing Factors in Bronchiectasis (2018) (1)
Impact of cough on insomnia and sleep quality in bronchiectasis (2020) (1)
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index (2015) (1)
Risk of a biased assessment of the evidence when limiting literature searches to the English language: macrolides in asthma as an illustrative example. (2015) (1)
Mediators of Inflammation in Pulmonary Diseases (2015) (1)
Immunodeficiency associated bronchiectasis in the European Bronchiectasis Registry (EMBARC) (2020) (1)
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) (2011) (1)
Efficacy and Safety of Different Doses of Tobramycin Inhalation Powder in Patients with Bronchiectasis and Pulmonary Pseudomonas Aeruginosa Infection: Results from the iBest-1 Study (2020) (1)
COPD SYMPTOMS, CIRCADIAN RHYTHM AND CLINICAL PHENOTYPES IN ITALIAN PATIENTS: BASELINE RESULTS OF THE STORICO COHORT OBSERVATIONAL STUDY (2018) (1)
Uneven distribution of professors and instructors in medical disciplines dealing with the four main chronic non-communicable diseases: the case of the Italian Universities (2017) (1)
Stromelysin-1 polymorphism as a new potential progression of chronic obstructive pulmonary disease (2009) (1)
PRS17 COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE:A HEALTH CARE ADMINISTRATIVE DATABASES ANALYSIS (2010) (1)
Treatable traits in interstitial lung diseases: a call to action. (2023) (1)
In Vitro Antibiotic Activity Against Chlamydia pneumoniae Clinical Isolates (2003) (1)
Nontuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review (2022) (1)
Proadrenomedullin improves the prognostic property of the BODE index (2012) (1)
Risk factors for new P. aeruginosa isolation in bronchiectasis- data from the European Bronchiectasis Registry (EMBARC) (2019) (1)
LACK OF PBC‐SPECIFIC ANTIMITOCHONDRIAL ANTIBODIES IN PATIENTS WITH CHLAMYDIA PNEUMONIAE INFECTION (2005) (1)
Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study (2020) (1)
Correction to: Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study (2019) (1)
Pneumonia Caused by Chlamydia pneumoniae (2005) (1)
Lung Transplant for ARDS after COVID-19: Long-Term Outcomes and Considerations about Detrimental Issues (2022) (1)
Hesitancy toward the Full COVID-19 Vaccination among Kidney, Liver and Lung Transplant Recipients in Italy (2022) (1)
Six Drivers to Face the XXI Century Challenges and Build the New Healthcare System: “La Salute in Movimento” Manifesto (2022) (1)
ACUTE EXACERBATIONS IN COPD (2009) (1)
FUNCTIONAL PROPERTIES OF DELETION-MUTANTS OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (1987) (1)
MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy (2021) (1)
Cardiac autonomic alterations impact early and late outcomes in patients with community-acquired pneumonia (2013) (1)
External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019 (2022) (1)
Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV” (2023) (1)
Vaccinazione antipneumococcica negli adulti : raccomandazioni della Società italiana di medicina respiratoria (SIMeR) e della Società italiana di igiene, medicina preventiva e sanità pubblica (SItI) = Pneumococcal vaccination in adults: recommendations from the Italian society of respiratory medicin (2014) (1)
Exploring the Anticancer Potential of Pyrazolo[1,2‐a]benzo[1,2,3,4]tetrazin‐3‐one Derivatives: The Effect on Apoptosis Induction, Cell Cycle and Proliferation. (2013) (1)
The Urokinase Plasminogen Activator Receptor as a Target for Cancer Therapy (2008) (1)
Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia (2020) (1)
Pathophysiology of Atypical Atrial Flutters. (2022) (1)
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD (2012) (1)
Pathophysiology and causes of haemoptysis (2016) (1)
A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italia (2010) (1)
Neutrophil Extracellular Traps are Increased in Severe Bronchiectasis and Reduced by Long-Term Azithromycin Treatment (2020) (1)
232 Purification and partial characterization of the cellular receptor for urokinase-type plasminogen activator (1988) (1)
The role of fluoroquinolones in the treatment of patients hospitalised with community-acquired pneumonia (2012) (1)
The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis (2021) (1)
Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? (2017) (1)
Accuracy of lung ultrasound in pleuritic chest pain: Preliminary data of a multicentric study (2015) (1)
Acute Improvements of Oxygenation with Cpap and Clinical Outcomes in Severe COVID-19 Pneumonia: A Multicenter, Retrospective Study (2022) (1)
OM-85 in the prevention of respiratory infections: State-of-the-art and future perspectives in clinical practice. (2021) (1)
Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry (2018) (1)
Etiology and investigation (2006) (1)
Chlamydia pneumoniae (2002) (1)
DNA binding proteins and regulation of the expression of the human urokinase-type plasminogen activator gene (1989) (1)
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy. (2022) (1)
Diagnosis of asthma: Laboratory procedures for identifying respiratory pathogens (1996) (1)
P142 IFNL3 polymorphisms and circulating levels are associated with COPD severity and outcomes (2017) (1)
Analysis of the role of Chest X-Ray in a large cohort of 1117 patients with SARS-CoV-2 infection: an Italian multicenter study (2020) (1)
Variability of Tidal Breathing Parameters in Preterm Infants and Associations with Respiratory Morbidity during Infancy: A Cohort-Study (2018) (1)
Newer Cephalosporins are Only Marginal Advancements Over Existing Compounds (2002) (1)
Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (2020) (1)
The role of inhaled antibiotics in bronchial infection. (2013) (1)
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis (2022) (1)
[Therapeutic experience with levofloxacin in pneumonia and COPD]. (2009) (1)
Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) (2011) (1)
Rhinosinusitis is associated with increased symptoms and more frequent exacerbations among patients with bronchiectasis- data from the EMBARC registry (2018) (1)
Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly (2009) (1)
Hyaluronic acid, heparan sulfate and chondroitin sulfate are altered during exacerbations of COPD (2017) (1)
Validation of MRSA Specific Scoring Systems Among Hospitalized Patients with CAP (2019) (1)
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). (2023) (1)
metalloproteinase-12: implication for angiogenesis in fibrin matrices Proteolysis of the urokinase-type plasminogen activator receptor by (2013) (1)
Hospital staff practical skills and theoretical knowledge in inhaled aerosol therapy: a single centre cross-sectional observational study. (2021) (1)
Lung Allograft Dysfunction in a COVID-19 Transplanted Patient is Associated with a Peculiar Immunopathological Phenotype (2021) (1)
LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study (2015) (1)
Corrigendum to "De-escalation therapy among bacteraemic patients with community-acquired pneumonia" [Clin Microbiol Infect 21 (2015) 936.e11-936.e18] (2015) (1)
Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD. (2018) (1)
1437: Evaluation of Epidermal Growth Factor Receptor and Urokinase-Type Plasminogen Activator Receptor in Serum of Prostate Cancer Patients (2007) (1)
Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry (2022) (1)
Perspectives and Perceptions on the Clinical Relevance of Chlamydia pneumoniae Infection (1995) (1)
Efficacy of inhaled dry powder tobramycin (TOBI Podhaler) in P. aeruginosa infected patients with bronchiectasis - iBEST study (2020) (1)
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) (2018) (1)
Binge Eating Disorder Treatment with Topiramate in a Patient with Bipolar Disorder (2013) (1)
Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC (2020) (1)
Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm (2017) (1)
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes (2018) (1)
Definition and aetiology of infective exacerbations of COPD. (2013) (1)
Respiratory viruses in stable state bronchiectasis (2019) (1)
Withdrawal: Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: Concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosph (2019) (1)
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients (2021) (1)
Role of Levofloxacin in the Treatment of Lower Respiratory Tract Infections (LRTIs) (2004) (1)
The Structure of the Human Plasminogen Activator (uPA) Gene (1985) (1)
Possible stage-specific function of NF-kappaB during pre-B cell differentiation. (1998) (1)
Bacterial Etiology of Community-Acquired Pneumonia and Appropriateness of Empirical Treatment Recommendations: An International Observational Cohort Study (2019) (1)
Community-acquired pneumonia in five European countries: Usage patterns and real-life effectiveness of antibiotics (REACH study) (2012) (0)
Chronic Bronchitis and Its Exacerbations: Definitions and Evaluations (2000) (0)
In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa (2018) (0)
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation (2018) (0)
Considerations on cardiac patients during Covid‐19 outbreak (2020) (0)
Primary graft dysfunction after lung transplantation: Medium and long term outcomes (2015) (0)
Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists (2022) (0)
Fumo e Patologie Correlate (2005) (0)
Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) (2014) (0)
Bronchiectasis in Italy: data from the national registry IRIDE (2020) (0)
Chronic obstructive pulmonary diseases in the elderly: a paradigm of complexity (2011) (0)
Buruli Ulcer, Nigeria (2007) (0)
Author response for "Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies" (2021) (0)
In vitro antimicrobial activity of ceftolozane/tazobactam against P. aeruginosa and other non-fermenting gram-negative organisms in adults with cystic fibrosis (2018) (0)
Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD (2014) (0)
Overview of mechanisms: Asthma versus chronic obstructive pulmonary disease (2010) (0)
Description of the Disease and Diagnostic and Epidemiologic Aspects (2010) (0)
(964) - EVLP: A Monocentric Five Year Experience (2017) (0)
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department (2014) (0)
Serum cytokines patterns in lung transplant recipients (2015) (0)
Post-COVID-19 sequelae (2021) (0)
Characteristics and outcomes of unvaccinated and vaccinated COVID-19 patients with acute respiratory failure treated with CPAP in a medical intermediate care unit (2023) (0)
Each day is a new beginning (2017) (0)
Late Breaking Abstract - Efficacy of DPP1 inhibition with brensocatib in subgroups of patients with bronchiectasis- the WILLOW study (2020) (0)
P085 Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter baumannii grown in biofilms (2018) (0)
IFNL3 polymorphisms are associated with COPD severity and outcomes (2017) (0)
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective (2018) (0)
[Mobbing, organizational dysfunction and bio-psycho-social effects: an integrated assessment. Preliminary data for the validation of the Questionnaire in the Neapoletan dialect on Distress at Work(Qn-DL)]. (2013) (0)
SARS and influenza, two respiratory diseases of viral origin: Possible sceneries for the present winter (2003) (0)
GRACE: spreading knowledge about community-acquired pneumonia (2006) (0)
Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries (2020) (0)
The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry (2021) (0)
Correlation between Air Pollution and Emergency Visits for Cardio-vascular and Respiratory Diseases in Milan, Italy. The POEMI Project. (2009) (0)
Assessment of tracheal tube biofilm translocation during mechanical ventilation and lung injury (2011) (0)
Lung Transplantation for Acute Respiratory Distress Syndrome Related to COVID-19: The Lesson Learned from the First Two Cases (2021) (0)
Considerations from the Epicenter of the Coronavirus Emergency (2020) (0)
Clinical Evolution and Quality of Life in Clinically Based COPD Chronic Bronchitic and Emphysematous Phenotypes: Results from the 1-Year Follow-Up of the STORICO Italian Observational Study (2021) (0)
Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis (2018) (0)
Impact of exacerbations in the natural course of COPD (2013) (0)
S. pneumoniae prevalence and serotypes in sputum of stable bronchiectasis (2019) (0)
Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients (2019) (0)
Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis (2018) (0)
Cardiovascular Autonomic Control in Lung Transplantation Recipients (2018) (0)
221 Subclinical right ventricular dysfunction and pulmonary hypertension detected by echocardiography in adults with cystic fibrosis (2011) (0)
Human I mmunodeficiency Virus S trains, and D isease P rogression (2000) (0)
Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs). (2004) (0)
KL-6 serum levels in adult cystic fibrosis patients (2011) (0)
Pharmacoeconomical analysis of AECB treatment using a computerised case report form (2000) (0)
Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation (2018) (0)
International Respiratory Infections Society COVID Research Conversations: Podcast 1 with Dr. Francesco Blasi (2021) (0)
What’s important for people with NTM? An EMBARC-ELF patient survey (2020) (0)
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (2020) (0)
Empiric Therapy in Community-Acquired pneumonia (2005) (0)
Use of dornase alfa in cystic fibrosis: an Audit of Italian specialists (2021) (0)
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score (2015) (0)
Assessment of Lumacaftor/Ivacaftor therapy on physical activity and exercise tolerance in adults with cystic fibrosis (2020) (0)
Duration of Antibiotic Therapy in Hospitalized Patients with Community-Acquired Pneumonia : Results from the CAPO International Cohort Study (2019) (0)
Perspectives and Perceptions on the Management of Acute Exacerbations of COPD (2000) (0)
Viral Respiratory Infections: From Bench to Bedside (2021) (0)
Putative role of antimicrobial activity in the treatment of asthma (2007) (0)
Pneumonia due to Mycoplasma, Chlamydophila and Legionella (2014) (0)
Atypical pathogens and COPD (2002) (0)
Additional file 1: Table SA. of Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study (2016) (0)
A broad immunological screening may impact treatment in bronchiectasis patients (2019) (0)
Ecocardiografia ed Ipertensione Arteriosa Polmonare Echocardiography and Pulmonary Arterial Hypertension (2007) (0)
Chapter-04 Atypical Pneumonias (2015) (0)
Implications of Chlamydia Pneumoniae in the etiopathogenesis of chronic pulmonary diseases (2002) (0)
Women’s Cardiac Health in 2020: A Systematic Review (2020) (0)
A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE (2020) (0)
Winter and "atypical" respiratory infections (2003) (0)
Role of β-lactams in the treatment of bacterial exacerbations of chronic bronchitis: critical examination and treatment recommendations. (2010) (0)
Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire (QoL-B) (2018) (0)
Respiratory viruses in adults with cystic fibrosis during stable and exacerbations (2019) (0)
Sputum colour: a marker of bacterial infection. (2013) (0)
Chlamydia Pneumoniae and Acute Aortic Syndrome: A Call for a Multi-Institutional Study Clamidia Pneumoniae e Sindromi aortiche acute: necessità di uno studio multicentrico (2008) (0)
The role of viruses in chronic bronchitis and exacerbations of COPD. (2013) (0)
Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms (2018) (0)
Epidemiology and factors associated with overweight in adults with cystic fibrosis: an Italian multicenter experience (2020) (0)
Antibiotics in the Treatment of Acute Exacerbations of Chronic Bronchitis: A Review of Controlled Clinical Trials (2000) (0)
2019 ATS/IDSA CRITERIA TO IDENTIFY P. AERUGINOSA AND MRSA PROMOTE OVERUTILIZATION OF MRSA THERAPY IN NON-SEVERE CAP (2020) (0)
Come scrivere un articolo scientifico = How to write a scientific paper (2010) (0)
Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry (2018) (0)
Ten Years of ECP for CLAD: A Real Life Experience. (2020) (0)
The role of pulmonary arterial wedge pressure in primary graft dysfunction (2018) (0)
Oto score and medium-term outcomes in lung transplantation (2016) (0)
Subject Index Vol. 78, 2009 (2009) (0)
Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry (2019) (0)
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study (2011) (0)
(984) – CMV: Reactivation and Prematurely Discontinued Prophylaxis (2017) (0)
Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease (2019) (0)
YOU DON’T FIND WHAT YOU DON’T LOOK FOR: PREVALENCE OF IMMUNODEFICIENCY IN PATIENTS WITH CYSTIC FIBROSIS USING A BROAD IMMUNOLOGICAL SCREENING (2020) (0)
OTO Score and medium-term survival in lung transplantation (2016) (0)
Prevalence of S. pneumoniae colonization and serotypes in sputum of vaccine-naive adults with cystic fibrosis (2019) (0)
Management of respiratory outpatients: A retrospective descriptive analysis (2019) (0)
Role of C. pneumoniae in severe asthma and COPD: Epidemiology and treatment (2000) (0)
Alterations of Eating Behaviour Related To Workplace Suffering. (2013) (0)
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia (2013) (0)
Treatment of difficult Gram-positive infections (2004) (0)
Urinary antigen detection in the diagnosis of Streptococcus pneumoniae infection (2004) (0)
Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis (2018) (0)
Irisin is associated with clinical outcomes and up-regulated by long-acting anticholinergics in COPD (2017) (0)
Treatment of dyspnea in do-not-intubate (DNI) patients: is NIV a sensible option? (2017) (0)
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA) (2023) (0)
Thrombocytosis in Patients With Severe Community-Acquired Pneumonia: Response (2010) (0)
Chronic obstructive pulmonary disease: the exacerbation (2006) (0)
The Best on Infections, update from the 2010 ERS Conference (2011) (0)
Antibiotic allergy in a COPD patient with frequent bacterial exacerbations (2007) (0)
Evidence for Chlamydia pneumoniae infection in cerebrospinal fluid of patients with multiple sclerosis (2000) (0)
Role of inhaled antibiotics in the era of highly effective CFTR modulators (2023) (0)
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) (2018) (0)
Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factor (1999) (0)
Chapter 11 Perspectives and Perceptions on the Clinical Relevance of Chlamydia pneumoniae Infection (1995) (0)
Chapter-05 Acute Exacerbations of Chronic Obstructive Pulmonary Disease (2013) (0)
Two ffamily ooutbreaks oof Chlamydia ppneumoniae infection (1994) (0)
Azathioprine discontinuation and medium and long term outcomes after lung transplantation (2015) (0)
ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training (2018) (0)
Enviromental pollution and emergency department admission for respiratory and cardiovascular diseases in Milan Italy. The POEMI project (2009) (0)
Fumo e patologie correlate: casi clinici in infettivologia patologica (2005) (0)
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection (2013) (0)
Relation of health-related quality of life, frequent exacerbation phenotype and circulating systemic biomarkers in stable COPD (2011) (0)
Non-Tuberculous Mycobacteria Testing in Bronchiectasis Patients in Europe: Data from the Embarc Registry (2020) (0)
Identifying patients with pneumonia due to MDR organisms coming from the community (2017) (0)
Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPD (2011) (0)
Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer (2008) (0)
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) (2014) (0)
Therapeutic approach in haemoptysis (2016) (0)
Nocardia infections after lung transplantation: a case series (2016) (0)
clinical investigations A Possible Association ofChlamydia pneumoniae Infection andAcute Myocardial Infarction inPatients Younger Than65YearsofAge (2015) (0)
Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens (2016) (0)
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis. (2023) (0)
Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry (2021) (0)
(520) - The Burden of Sinus Disease in Cystic Fibrosis Lung Transplant Recipients (2017) (0)
The best on infections: update from the 2010 ERS Congress (2011) (0)
Acute Respiratory Distress Syndrome in Mechanically-Ventilated Patients with Community-Acquired Pneumonia (2018) (0)
CF sinus disease after lung transplantation (2016) (0)
Acute e exacerbations o of a asthma iin a adults: role o of Chlamydia P Pneumoniae infection (1994) (0)
Elevated TNF-± And Interleukin-6 Levels In Breath Condensate And Serum Of Patients With Non-CF Bronchiectasis Comparison To COPD (2012) (0)
Five years of EVLP: a monocentric experience (2017) (0)
The impact of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (2011) (0)
Effect on the body supine position on diffusion capacity in sclerodermic patients (2004) (0)
Antibiotic treatment and prevention of exacerbations of COPD. (2013) (0)
Acute exacerbation of COPD: application of evidence-based guidelines (2009) (0)
Obstructive Airways Disease Implications of Chlamydia Pneumoniae in the Etiopathogenesis of Chronic Pulmonary Diseases (2002) (0)
University of Dundee European Respiratory Society guidelines for the management of adult bronchiectasis Polverino, (2017) (0)
Respiratory failure in COVID-19: a patient's perspective and clinical cases (2021) (0)
Immune Checkpoint Espression Associates with Rejection in Lung Transplant Recipients (2021) (0)
LATE-BREAKING ABSTRACT: Intra-day symptoms fluctuations: STORICO, observational study on the characterization of 24-hour symptoms in COPD patients (2016) (0)
Bacterial airway colonization is not associated with increased procalcitonin in stable COPD (2012) (0)
Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patients (2015) (0)
Intensive care unit acquired pneumonia with or without etiologic diagnosis: A comparison of outcomes (2012) (0)
Molecular Imaging of Thrombosis and Thrombolysis (2014) (0)
PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis (2020) (0)
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study (2011) (0)
Tobramycin by aerosol (Toby ® )eradicates Pseudomonas aeruginosa resistant to Tobramycin i.v. in patients with infected bronchiectasis (2001) (0)
TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF) (2020) (0)
CYSTIC FIBROSIS PATIENT WITH SEVERE RESPIRATORY FAILURE: RAPID RESOLUTION OF ATELECTASIS WITH NIMV (2008) (0)
P104 Prevalence, clinical characteristics and outcomes of patients referred to an adult cystic fibrosis centre from pulmonary clinics (2018) (0)
Cardiovascular autonomic alterations and severity of the disease in community-acquired pneumonia (2013) (0)
Neutrophil elastase is correlated with disease severity in a cohort from Southern Europe (2020) (0)
Role of Mycoplasma and Chlamydia in the Natural History of COPD (2005) (0)
There is still no established and accepted definition of COPD. (2023) (0)
IPD2.07 Retrospective observational study in cystic fibrosis patients homozygous for F508del treated with lumacaftor/ivacaftor in a compassionate use programme (2018) (0)
Pneumonia: how important are local epidemiology and smoking habits? (2016) (0)
Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry (2021) (0)
Annals of Clinical Case Reports Effects of Lumacaftor/Ivacaftor Therapy on Exercise Endurance and Inspiratory Capacity in Cystic Fibrosis (2022) (0)
Chlamydia pneumoniae: A New Threat for HIV-infected Subjects (1999) (0)
General pharmacological considerations in antibiotic treatment of community-acquired pneumonia. (2008) (0)
Chest Physiotherapy in patients with Bronchiectasis – what is the current practice in Europe? (2018) (0)
POSITIVE LUNG I-131 WHOLE SCAN IN A THYROIDECTOMIZED CYSTIC FIBROSIS PATIENT FOR THYROID CANCER: CYSTIC FIBROSIS PULMONARY INVOLVEMENT OR THYROID METASTASIS? (2008) (0)
Comparison between different bacterial sampler chambers applied on a portable aerodispersed particle sampler (partrap FA52) used for aerobiological studies in sanitary environments (2000) (0)
Epidemiology of clinical trials in respiratory diseases in Europe and Italy (2015) (0)
Are antibiotics useful in acute exacerbations of chronic bronchitis (2004) (0)
The effect of amoxicillin in lower respiratory tract infection (LRTI): A placebo controlled RCT in 16 primary care GRACE networks from 12 countries in Europe (2011) (0)
[A data base of a thoracic and cardiovascular department: information on 1001 patients]. (2012) (0)
MRSA specific scores promote overuse of anti-MRSA antibiotics (2019) (0)
Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosis (2021) (0)
Etiology Issues and Problems of Antibiotic Resistance (2010) (0)
Pulmonary Tuberculosis Management: 2015 Update (2015) (0)
Adrenomedullin optimizes mortality prediction in COPD (2014) (0)
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity (2015) (0)
Performing and Interpreting Spirometry: Understanding and Implementing the ATS/ERS Guidelines (2018) (0)
The Prescribing Practice for COPD: Relationship to Circadian Rhythm, Disease Severity, and Clinical Phenotype in the STORICO Observational Study (2022) (0)
Chlamydia pneumoniae Pneumonia: Radiological Features (1995) (0)
The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy (2022) (0)
Chronic infection with chlamydia pneumoniae is related to the severity of asthma (1999) (0)
Pneumonia and other infectious diseases (2014) (0)
Pathogeneia ton loimoxeon tou anapneustikou sustematos (2010) (0)
Contents (2020) (0)
The Metagenomic ‘Bacteriophagome’ in Bronchiectasis (2021) (0)
University of Dundee A comprehensive approach to lung function in bronchiectasis Radovanovic, (2018) (0)
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients (2022) (0)
The Spectrum of Bronchial Infection (2013) (0)
Chlamydia/Mycoplasma Do They Precipitate Acute Asthma Attacks? (2003) (0)
P0569ACUTE KIDNEY INJURY AFTER LUNG TRANSPLANTATION: INCIDENCE, RISK FACTORS AND OUTCOMES IN A MONOCENTRIC RETROSPECTIVE COHORT STUDY (2020) (0)
Phenotyping in bronchiectasis: Are we moving toward a personalized medicine? (2016) (0)
Usefulness of Specific Airway Resistance in Preschool Children with Cystic Fibrosis (2005) (0)
Helicobacter pylon DNA is not detected in atherosclerotic plaques obtained from patients with H. pylori infection (2001) (0)
Characteristics and outcomes of adults with primary ciliary dyskinesia (PCD): an EMBARC/BEAT-PCD analysis (2021) (0)
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)? (2011) (0)
Contents Vol. 78, 2009 (2009) (0)
Response. (2021) (0)
P098 The “rare-exacerbator” status in adult cystic fibrosis patients (2018) (0)
WS20.6 The burden of sinus disease in cystic fibrosis lung transplant recipients (2016) (0)
Pharmacological and Pharmacoeconomic Considerations (2010) (0)
COPD on anti-GERD therapy remains at higher risk for severe exacerbation (2014) (0)
The efficacy of mineral corticoid receptor antagonist, canrenone, in COVID-19 patients (2020) (0)
Rational use of tuberculosis drugs to prevent the development of drug resistance (2012) (0)
Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology (2013) (0)
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia (2014) (0)
Basal membrane biomarkers in stable and exacerbated COPD (2017) (0)
Obesità e patologie correlate (2006) (0)
P143 Collagen degradation and formation markers in stable and exacerbated COPD (2017) (0)
The burden of sinus disease in CF candidates for lung transplantation (2016) (0)
Carbapenem-Resistant Klebsiella Pneumoniae in Lung Transplantation Recipients (2016) (0)
Synergistic activity of N-acetylcysteine and colistin against Stenotrophomonas maltophilia (2017) (0)
Reviewers of the Journal of Chemotherapy (2010) (0)
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis (2022) (0)
One-Year Evolution of Symptoms and Health Status of the COPD Multi-Dimensional Phenotypes: Results from the Follow-Up of the STORICO Observational Study (2021) (0)
PTPe (RPTPe and Cyt-PTPe) (2012) (0)
uPAR and Proteases in Mobilization of Hematopoietic Stem Cells (2008) (0)
110 Serum Levels of Urokinase-Type Plasminogen Activator Receptor and Epidermal Growth Factor Receptor in Patients With Prostate Cancer and Benign Prostatic Hyperplasia (2007) (0)
The transcription factor PREP1(PKNOX1) regulates nuclear stiffness, the expression of LINC complex proteins and mechanotransduction (2022) (0)
PCAF Lysine Acetyltransferase (2008) (0)
Liver HBV replication in HBsAg+ patients with and without HDV superinfection (1989) (0)
internalization anddegradation of urokinase iscausedbyitsspecific inhibitor PAI-1 (1990) (0)
The GPI-anchored Urokinase Receptor (uPAR) dynamics on the cells surface followed by fluorescence fluctuation spectroscopy. (2005) (0)
17 The enhancer of the human uPA gene is accessible to trancription factors in both uninduced and TPA-induced HepG2 cells (1997) (0)
Regulation of urokinase:PAI-1 internalization: coordinate expression of the urokinase and the α2-macroglobulin receptors (1994) (0)
Ligand-dependent co-capping of uPA receptor with intracellular tyrosine-phosphorylated proteins (1994) (0)
Regulation der Glucosehomöostase im Skelettmuskel durch den Transkriptionsfaktor Prep1 (2011) (0)
Process for the preparation of urokinase enkeltkaedet (1988) (0)
Erratum: A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny (Development vol. 132 (3113-3126)) (2005) (0)
42 Type-1 plasminogen activator inhibitor (PAI-1): Cell-specific expression and hormonal regulation in human cell lines (1988) (0)
Tumor necrosis factor-alpha regulates urokinase-type plasminogen activator and its type-1 inhibitor in human neoplas71c cell lines (1989) (0)
Urokinase (Plasminogen Activator, u-PA, pro-u-PA, scu-PA) (2002) (0)
Rapid and reversible changes in the chromatin structure of the enhancer are responsible for the induction of the human uPA gene by TPA (1996) (0)
Antibodies that modulate the uPA / uPAR interaction and uses thereof. (2002) (0)
Hormonal regulation of human urokinase transcription in sertoli cells (1990) (0)
through a p 160-Mediated Mechanism Diabetes and Increased Insulin Sensitivity Prep 1 Deficiency Induces Protection from (2008) (0)
104 Urokinase receptor in serum of ovarian cancer patients (1997) (0)
ThemechanismsofBMhematopoieticstem/progenitorcell(HSPC)adhesion,engraftment,andmobilization remainincompletelyidentified.Here,usingWTandtransgenicmice,wehaveshownthatmembrane-anchored plasminogenactivator,urokinasereceptor( M uPAR)marksasubsetofHSPCsandpromotesthepreserva- tionofthesizeofthispoolofc (2009) (0)
Novel roles of plasmin, uPAR and suPAR in mobilization and retention of HSC/HPCs (2005) (0)
PC-1 (Human) (2012) (0)
Activateurs de plasminogene phosphoryles (1990) (0)
Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor (plasminogen activator/in vitro synthesis/immunoblotting/immunofluorescce/fibrinolysis) (2016) (0)
Role of the urokinase receptor uPAR and plasmin in the maintenance, engraftment and mobilization of hematopoietic progenitor cells (2007) (0)
A soluble form of the urokinase receptor inhibits monocyte migration by preventing in-tegrin-dependent cell adhesion (2004) (0)
Transforming growth factor-beta induces incresed level of plasminogen activator inhibitor mRNA in human lung fibroblasts (1987) (0)
Regulation of type-1 plasminogen activator inhibitor (PAI-1) gene expression in human cell lines (1989) (0)
Activator Protein 1 Chronically Infected U 1 Cells via Inhibition inInduced HIV-1 and Chemokine Expression Pertussis Toxin B-Oligomer Suppresses IL-6 (2005) (0)
Structure, Function and Regulation of the Urokinase Receptor (1995) (0)
Thymopoiesis Mitogenic Stimuli , But Not to Abnormal Increased Cell Apoptosis in Response to Proliferation and Cytokine Production and to Cells Leads to a Dramatic Decrease in Cell B in T-Lineage κ In Vivo Inhibition of NF - (1999) (0)
hematopoietic stem cell mobilization Involvement of the urokinase-type plasminogen activator receptor in (2008) (0)
Antibodies for modulating the upa / upar interaction and their uses (2002) (0)
Molecular Basis for Plasminogen Activation, Surface Proteolysis, and Their Relation to Cancer (2020) (0)
20 The role of downstream sequences in the regulation of transcriptional activity of the human urokinase receptor promoter (1997) (0)
SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER (2006) (0)
Functional separation between uPA-roducing and uPA-clearing areas during mouse embryo implantation (1994) (0)
DOP002 Conditional deletion of Prep1 in the intestinal epithelium alters epithelial homeostasis, intestinal development, and controls colitis susceptibility (2014) (0)
Structural studies on the urokinase plasminogen activator receptor (uPAR), a key mediator of cancer invasiveness (2004) (0)
5 Prep1: a new player in the development of IBD-associated fibrosis (2013) (0)
Specificity and Properties of the Human Urokinase Receptor (2020) (0)
expression in monocytic cells and activation of the CD11b/CD18 (Mac1) integrin inhibit late events of HIV Ligand-engaged urokinase-type plasminogen activator receptor (uPAR) (2013) (0)
Decrease Rapidly during Chemotherapy Circulating Tumor Cells in Acute Myeloid Leukemia and Soluble Urokinase Receptor Levels Correlate with Number of Updated Version (2000) (0)
Abstracts of papers presented at the 1993 Meeting on Molecular & Cellular Biology of Plasminogen Activation, September 28-October 3, 1993 (1993) (0)
Prep1 prevents premature adipogenesis of mesenchymal progenitors (2017) (0)
The urokinase receptor as an effector of G protein-coupled receptors (2002) (0)
Transforming growth factor-β and glucocorticoid regulation of plasminogen activator inhibitor type-1 (1987) (0)
Short and long term effects of tumor promoter PMA on the interaction between u-PA and its receptor (1989) (0)
3 A novel homeo-domain protein, prep1, forms a regulatory complex with PBX proteins in vivo (1997) (0)
the human uPA gene and invasive potential of PC3 cells Binding of Sp1 to the proximal promoter links constitutive expression of (2013) (0)
Molecular studies of the cellular receptor for urokinase-type plasminogen activator (1988) (0)
Mo1273 Prep1: A New Player in the Development of IBD-Associated Fibrosis (2013) (0)
SP enhances the Ige Mediated release of cytokine from uterine mast cells: Neuroimmune network during reproductive cycle (1994) (0)
Demonstration of the cellular receptor for urokinase-type plasminogen activator in human chorion (1989) (0)
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder (2005) (0)
Novel Role of Plasmin in Mobilization and of uPAR in Retention of Hematopoietic Stem/Progenitor Cells in the Bone Marrow Niche: Therapeutic Implications. (2004) (0)
The urokinase receptor, cell migration, proliferation and cancer (2006) (0)
Expression of Concern. Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase. Diabetes 2011;60:138–147. DOI: 10.2337/db10-0860. PMID: 20864515 (2017) (0)
Structure, function, localization and regulation of the upa receptor, uPAR (1994) (0)
Possible stage-speci¢c function of NF-UB during pre-B cell di¡erentiation (1998) (0)
Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor ( plasminogen activator / in vitro synthesis / immunoblotting / immunofluorescence / fibrinolysis ) (0)
Plasminogen activator receptor-urokinase (1990) (0)
Correction: Characterization of the Regulatory Region of the Zebrafish Prep1.1 Gene: Analogies to the Promoter of the Human PREP1 (2011) (0)
25 Upstream promoter elements required for basal and monocyte specific transcription of the human urokinase receptor gene (1997) (0)
A truncated form of the urokinase receptor which is retained intracellularly in the unglycosylated state (1990) (0)
The urokinase receptor is unable to couple with the mitogenic signaling pathways in the myeloid cell line 32D (1996) (0)
Short title: uPA/uPAR and MAC-1 inhibit late HIV expression (2008) (0)
Results LRP / a 2-MR Dependence of the Internalization of the uPA-Serpin Complexes in U 937 and LB 6 Clone 19 Cells (2002) (0)
37 Urokinase receptor mediated vitronectin adhesion of transfected myeloid 32D cells (1997) (0)
Type-1 plasminogen activator inhibitor (PAI-1): Cell-specific expression and hormonal regulation in human cell lines (1988) (0)
Interaction between receptor-bound uPA and its inhibitor type-1 (PAI-1) in human U937 cells (1989) (0)
immunodeficiency virus infection a strong and independent predictor of survival in human Serum level of soluble urokinase-type plasminogen activator receptor is (2013) (0)
Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease (2016) (0)
The antimicrobial resistome in bronchiectasis: an international multicentre study (2022) (0)
ePS3.08 Inhaled powder tobramycin (TIP): cyclical versus continuous treatment: iBEST Study (2022) (0)
Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (2021) (0)
POSA59 Using Disease Registries for Cost of Illness Studies: The European Bronchiectasis Registry Case (2022) (0)
Characterization of Ciliary Function in Bronchiectasis (EMBARC-BRIDGE Study) (2022) (0)
Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (2021) (0)
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review (2014) (0)
The role of the NLRP3 inflammasome in mucociliary clearance in bronchiectasis: The EMBARC-BRIDGE study (2022) (0)
Serum levels of glycosaminoglycans are altered during acute exacerbations in chronic obstructive pulmonary disease: 117 (2017) (0)
The Relationship Between Airway Interleukin-1 Beta, Microbial Dysbiosis and Mucus Hyperconcentration in Bronchiectasis: The EMBARC-BRIDGE Study (2022) (0)
An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here? (2021) (0)
404 Acute coronary syndromes after healing from COVID-19: report of the initial observation (2021) (0)
298 Domiciliary periodic Levosimendan infusions in advanced heart failure: a single centre experience (2021) (0)
Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis. (2022) (0)
845 THE PREDICTIVE ROLE OF HIGH-SENSITIVITY CARDIAC TROPONIN T IN THE EMERGENCY ROOM: COMBINING BIOMARKERS WITH CLINICAL DATA LEADS TO THE DIAGNOSIS OF CARDIOVASCULAR DISEASE (2022) (0)
512 Long-term survival in patients with post-operative atrial fibrillation after cardiac surgery: analysis from a prospective-cohort study (2021) (0)
528 Advanced echocardiographic assessment in outpatients with advanced heart failure undergoing periodical levosimendan infusion (2021) (0)
The tailor-made treatment in a particular case of pulmonary hypertension in thalassaemia intermedia: a case report (2021) (0)
512 Long-termsurvivalinpatientswithpost-operativeatrialfibrillationafter cardiacsurgery:analysisfromaprospective-cohortstudy (2021) (0)
XV CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Naples, Italy - May 20-23, 2015 - Program (Summary) (2015) (0)
Atypical Cases of Typical Atrial Flutter? A Case Study. (2022) (0)
455 Haemodynamic prediction of primary graft dysfunction in lung transplant recipients (2021) (0)
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation (2023) (0)
Clinical Characteristics and Outcomes of Patients with Acute Respiratory Failure Due to SARS-CoV-2 Interstitial Pneumonia Treated with CPAP in a Medical Intermediate Care Setting: A Retrospective Observational Study on Comparison of Four Waves (2023) (0)
Safety and Immunogenicity of the AntiCOVID19 Vaccines in a Cohort of Lung Transplant Recipients (2023) (0)
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review (2023) (0)
PD-1 expression in transbronchial biopsies of lung transplant recipients is a possible early predictor of rejection (2023) (0)
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience (2022) (0)
Impact of underlying disease on long-term skeletal outcome after lung transplantation (2022) (0)
Acute Kidney Injury in Non-Intensive Care Unit (ICU) Hospitalizations for Coronavirus Disease (COVID-19) (2022) (0)
Bone Disease in Long-Term Lung Transplant Survivors (2023) (0)
Corrigendum to ‘External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019’ (2022) (0)
Lung Transplantation From Controlled and Uncontrolled Donation After Circulatory Death (DCD) Donors With Long Ischemic Times Managed by Simple Normothermic Ventilation and Ex-Vivo Lung Perfusion Assessment (2023) (0)
Longitudinal assessment of renal function after lung transplantation for cystic fibrosis: transition from post-operative acute kidney injury to acute kidney disease and chronic kidney failure (2022) (0)
DIAGNOSTIC TRAJECTORIES OF INTERSTITIAL LUNG DISEASE AFTER IMPLEMENTATION OF A MULTIDISCIPLINARY DISCUSSION TEAM MEETING (2020) (0)
Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time (2022) (0)
Interventional pulmonology techniques in lung transplantation. (2023) (0)
Microbial inflammatory networks in bronchiectasis exacerbators with Pseudomonas aeruginosa. (2023) (0)
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) (2023) (0)

This paper list is powered by the following services:

Other Resources About Francesco Blasi

en.wikipedia.org

What Schools Are Affiliated With Francesco Blasi?

Francesco Blasi is affiliated with the following schools:

Francesco Blasi's Academic­Influence.com Rankings